Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Diabetes Drugs Market


6. Market Share – Global Diabetes Drugs Market

6.1 By Disease Type
6.2 By Therapy – (Oral, Injection, Insulin)
6.3 By Oral Drug
6.4 By Injection Drug
6.5 By Insulin
6.6 By Regions


7. Disease Type – Global Diabetes Drugs Market

7.1 Type 1 Diabetes Drug Market
7.2 Type 2 Diabetes Drug Market


8. Therapy - Global Diabetes Drugs Market

8.1 Oral

8.1.1 (DPP) IV inhibitor
8.1.2 SGLT – 2
8.1.3 Alpha Glucosidase Inhibitor
8.1.4 Biguanide
8.1.5 Others Oral Drug

8.2 Injection

8.2.1 Glucagon-like peptide (GLP) 1 agonist
8.2.2 Amylin receptor agonist

8.3 Insulin

8.3.1 Rapid – Acting Insulin
8.3.2 Long Acting Insulin
8.3.3 Premixed Insulin
8.3.4 Other Insulin


9. Region - Global Diabetes Drugs Market

9.1 North America
9.2 Europe
9.3 Asia Pacific
9.4 The Middle East & Africa


10. Porters Five Forces

10.1 Overview
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Degree of Competition
10.5 Threat of New Entrants
10.6 Threat of Substitutes


11. Company Analysis

11.1 Novo Nordisk

11.1.1 Overview
11.1.2 Recent Development & Strategies
11.1.3 Financial Insights

11.2 AstraZeneca plc

11.2.1 Overview
11.2.2 Recent Development & Strategies
11.2.3 Financial Insights

11.3 Biocon

11.3.1 Overview
11.3.2 Recent Development & Strategies
11.3.3 Financial Insights

11.4 Sanofi

11.4.1 Overview
11.4.2 Recent Development & Strategies
11.4.3 Financial Insights

11.5 Eli Lilly

11.5.1 Overview
11.5.2 Recent Development & Strategies
11.5.3 Financial Insights

11.6 Johnson & Johnson

11.6.1 Overview
11.6.2 Recent Development & Strategies
11.6.3 Financial Insights

11.7 Bristol Myers Squibb Co.

11.7.1 Overview
11.7.2 Recent Development & Strategies
11.7.3 Financial Insights



List of Figures

Figure-01: Global – Diabetes Drug Market (Million US$), 2016 – 2021
Figure-02: Global – Forecast for Diabetes Drug Market (Million US$), 2022 – 2027
Figure-03: Disease Type – Type 1 Diabetes Drug Market Market (Million US$), 2016 – 2021
Figure-04: Disease Type – Forecast for Type 1 Diabetes Drug Market Market (Million US$), 2022 – 2027
Figure-05: Disease Type – Type 2 Diabetes Drug Market Market (Million US$), 2016 – 2021
Figure-06: Disease Type – Forecast for Type 2 Diabetes Drug Market Market (Million US$), 2022 – 2027
Figure-07: Oral – (DPP) IV inhibitor Market (Million US$), 2016 – 2021
Figure-08: Oral – Forecast for (DPP) IV inhibitor Market (Million US$), 2022 – 2027
Figure-09: Oral – SGLT – 2 Market (Million US$), 2016 – 2021
Figure-10: Oral – Forecast for SGLT – 2 Market (Million US$), 2022 – 2027
Figure-11: Oral – Alpha Glucosidase Inhibitor Market (Million US$), 2016 – 2021
Figure-12: Oral – Forecast for Alpha Glucosidase Inhibitor Market (Million US$), 2022 – 2027
Figure-13: Oral – Biguanide Market (Million US$), 2016 – 2021
Figure-14: Oral – Forecast for Biguanide Market (Million US$), 2022 – 2027
Figure-15: Oral – Others Oral Drug Market (Million US$), 2016 – 2021
Figure-16: Oral – Forecast for Others Oral Drug Market (Million US$), 2022 – 2027
Figure-17: Injection – Glucagon-like peptide (GLP) 1 agonist Market (Million US$), 2016 – 2021
Figure-18: Injection – Forecast for Glucagon-like peptide (GLP) 1 agonist Market (Million US$), 2022 – 2027
Figure-19: Injection – Amylin receptor agonist Market (Million US$), 2016 – 2021
Figure-20: Injection – Forecast for Amylin receptor agonist Market (Million US$), 2022 – 2027
Figure-21: Insulin – Rapid – Acting Insulin Market (Million US$), 2016 – 2021
Figure-22: Insulin – Forecast for Rapid – Acting Insulin Market (Million US$), 2022 – 2027
Figure-23: Insulin – Long Acting Insulin Market (Million US$), 2016 – 2021
Figure-24: Insulin – Forecast for Long Acting Insulin Market (Million US$), 2022 – 2027
Figure-25: Insulin – Premixed Insulin Market (Million US$), 2016 – 2021
Figure-26: Insulin – Forecast for Premixed Insulin Market (Million US$), 2022 – 2027
Figure-27: Insulin – Other Insulin Market (Million US$), 2016 – 2021
Figure-28: Insulin – Forecast for Other Insulin Market (Million US$), 2022 – 2027
Figure-29: America – Diabetes Drug Market (Million US$), 2016 – 2021
Figure-30: America – Forecast for Diabetes Drug Market (Million US$), 2022 – 2027
Figure-31: Europe – Diabetes Drug Market (Million US$), 2016 – 2021
Figure-32: Europe – Forecast for Diabetes Drug Market (Million US$), 2022 – 2027
Figure-33: Asia Pacific – Diabetes Drug Market (Million US$), 2016 – 2021
Figure-34: Asia Pacific – Forecast for Diabetes Drug Market (Million US$), 2022 – 2027
Figure-35: Middle East & Africa – Diabetes Drug Market (Million US$), 2016 – 2021
Figure-36: Middle East & Africa – Forecast for Diabetes Drug Market (Million US$), 2022 – 2027
Figure-37: Novo Nordisk – Global Revenue (Million US$), 2016 – 2021
Figure-38: Novo Nordisk – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-39: AstraZeneca plc – Global Revenue (Million US$), 2016 – 2021
Figure-40: AstraZeneca plc – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-41: Biocon – Global Revenue (Million US$), 2016 – 2021
Figure-42: Biocon – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-43: Sanofi – Global Revenue (Million US$), 2016 – 2021
Figure-44: Sanofi – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-45: Eli Lilly – Global Revenue (Million US$), 2016 – 2021
Figure-46: Eli Lilly – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-47: Johnson & Johnson – Global Revenue (Million US$), 2016 – 2021
Figure-48: Johnson & Johnson – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-49: Bristol Myers Squibb Co. – Global Revenue (Million US$), 2016 – 2021
Figure-50: Bristol Myers Squibb Co. – Forecast for Global Revenue (Million US$), 2022 – 2027

List of Tables

Table-01: Global – Diabetes Drug Market Share by Disease Type (Percent), 2016 – 2021
Table-02: Global – Forecast for Diabetes Drug Market Share by Disease Type (Percent), 2022 – 2027
Table-03: Global – Diabetes Drug Market Share by Therapy (Percent), 2016 – 2021
Table-04: Global – Forecast for Diabetes Drug Market Share by Therapy (Percent), 2022 – 2027
Table-05: Global – Diabetes Drug Market Share by Oral Drug (Percent), 2016 – 2021
Table-06: Global – Forecast for Diabetes Drug Market Share by Oral Drug (Percent), 2022 – 2027
Table-07: Global – Diabetes Drug Market Share by Injection Drug (Percent), 2016 – 2021
Table-08: Global – Forecast for Diabetes Drug Market Share by Injection Drug (Percent), 2022 – 2027
Table-09: Global – Diabetes Drug Market Share by Insulin (Percent), 2016 – 2021
Table-10: Global – Forecast for Diabetes Drug Market Share by Insulin (Percent), 2022 – 2027
Table-11: Global – Diabetes Drug Market Share by Region (Percent), 2016 – 2021
Table-12: Global – Forecast for Diabetes Drug Market Share by Region (Percent), 2022 – 2027